Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse [Phase 2]
Phase 2 study evaluating DCEP (dexamethasone, cisplatin, etoposide, cyclophosphamide) in combination with thalidomide as salvage therapy for…
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: Dexamethasone or Dexamethasone in Combination With Thalidomide as Salvage Therapy [Phase 2]
Phase 2 trial evaluating dexamethasone alone or in combination with thalidomide as salvage therapy for multiple myeloma; the study is comple…
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: Anti-Angiogenesis Therapy Using Thalidomide in Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating thalidomide as an anti-angiogenesis therapy in multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma [Phase 3]
Phase 3 trial update comparing the D.T. PACE chemotherapy regimen against high-dose melphalan with autologous transplant in patients with pr…
-
CLINICAL_TRIALS trial_result · 2010-07-02Clinical Trial Update: Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II [Phase 3]
A Phase 3 trial evaluating the combination of bortezomib and lenalidomide (Revlimid) for patients with multiple myeloma who relapsed or prog…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-06-29Clinical Trial Update: Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma [Phase 2]
This update reports results from a Phase 2 study evaluating weekly bortezomib (Velcade) in patients with refractory multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Efficacy of Bortezomib Consolidation After High-dose Melphalan With Stem Cell Support in Myeloma Patients [Phase 3]
A Phase 3 trial evaluated whether consolidating with bortezomib after high-dose melphalan with stem cell support improves outcomes in multip…
-
CLINICAL_TRIALS trial_result · 2010-06-22Clinical Trial Update: Bortezomib and High-dose Melphalan at Myeloma Relapse [Phase 2]
Clinical trial update for a Phase 2 study evaluating bortezomib combined with high-dose melphalan for relapsed multiple myeloma. The current…
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: O6-benzylguanine And Carmustine in Treating Patients With Multiple Myeloma [Phase 2]
Phase II trial evaluating the combination of O6-benzylguanine and carmustine in patients with multiple myeloma. The study has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: High-Dose Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 trial evaluating high-dose chemotherapy followed by peripheral stem cell transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: A Study to Evaluate Two Different Regimens of VELCADE in Combination With Dexamethasone, Thalidomide and Cyclophosphamide (VDT vs VDTC) in Newly Diagnosed Multiple Myeloma [Phase 2]
A Phase 2 study comparing two VELCADE-based regimens (VDT vs VDTC) in combination with dexamethasone, thalidomide, and cyclophosphamide for …
-
CLINICAL_TRIALS trial_result · 2010-06-04Clinical Trial Update: Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy [Phase 3]
This Phase 3 trial update reports on an influenza A(H1N1) vaccine evaluated in adults with lymphoid malignancies undergoing chemotherapy. Th…
-
CLINICAL_TRIALS trial_result · 2010-05-13Clinical Trial Update: Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation [Phase 2]
A Phase 2 trial evaluating tacrolimus and mycophenolate mofetil to prevent acute graft-versus-host disease in patients with advanced hematol…
-
CLINICAL_TRIALS trial_result · 2010-05-06Clinical Trial Update: A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation [Phase 2]
Phase 2 study evaluating Lupron Depot to enhance immune function after bone marrow transplantation was terminated, with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2010-05-05Clinical Trial Update: Study of Immune Response Modifier in the Treatment of Hematologic Malignancies [Phase 2]
Phase 2 trial of an immune response modifier in hematologic malignancies has terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: IFM 99-02 Thalidomide in Myeloma [Phase 3]
Phase 3 trial IFM 99-02 evaluating thalidomide in multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-02Clinical Trial Update: Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 2]
A Phase 2 clinical trial evaluating bone marrow transplantation in patients with hematologic cancers has completed. The trial covered severa…
-
CLINICAL_TRIALS trial_result · 2010-03-17Clinical Trial Update: Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer [Phase 1]
Phase 1 clinical trial evaluating cyclophosphamide and/or mycophenolate mofetil with or without tacrolimus in patients undergoing donor bone…
-
CLINICAL_TRIALS trial_result · 2010-03-11Clinical Trial Update: Predictive Value of the "Cytocapacity Test" Patients With Lymphoproliferative Diseases and High-dose Therapy [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluated the predictive value of the Cytocapacity Test in patients with Hodgkin lymphoma, Non-Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: MS-275 in Treating Patients With Hematologic Cancer [Phase 1]
A Phase 1 trial of MS-275 (entinostat) in patients with hematologic cancers, including leukemia, multiple myeloma/plasma cell neoplasms, and…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [Phase 1]
Phase 1 trial of cyclophosphamide followed by bone marrow transplantation for hematologic cancers has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-03Clinical Trial Update: CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma [Phase 3]
A Phase 3 trial comparing lenalidomide plus dexamethasone versus dexamethasone alone in previously treated multiple myeloma has completed, w…
-
CLINICAL_TRIALS trial_result · 2010-03-03Clinical Trial Update: Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma [Phase 3]
Phase 3 expanded-access trial evaluating lenalidomide with or without dexamethasone in previously treated multiple myeloma completed, with r…
-
CLINICAL_TRIALS trial_result · 2010-02-22Clinical Trial Update: Study of XL999 in Patients With Multiple Myeloma [Phase 2]
A Phase 2 clinical trial of XL999 in patients with multiple myeloma was terminated.
-
CLINICAL_TRIALS trial_result · 2010-02-18Clinical Trial Update: Multiple Myeloma Treated With Thalidomide Before Autotransplant or With Conventional Chemotherapy and as Consolidation/Maintenance Treatment in Young and Elderly Patients : 3 Randomized Studies. [Phase 3]
Three randomized Phase 3 trials evaluate thalidomide as upfront therapy before autologous stem cell transplant or with conventional chemothe…